HALO 110-101: Phase Ib study of PEGPH20 in combination with cisplatin plus gemcitabine (PEGCISGEM) or atezolizumab (ATEZO) plus CIS plus GEM (PEGCISGEMATEZO) in patients with locally advanced/metastatic cholangiocarcinoma and gallbladder cancer Meeting Abstract
| Authors: | Oh, D. Y.; Park, J. O.; Charoentum, C.; Stein, S.; Noel, M.; Chung, V.; Wu, W.; Alton, R.; Muhsin, M.; Javle, M.; Abou-Alfa, G. K.; Borad, M. J. |
| Abstract Title: | HALO 110-101: Phase Ib study of PEGPH20 in combination with cisplatin plus gemcitabine (PEGCISGEM) or atezolizumab (ATEZO) plus CIS plus GEM (PEGCISGEMATEZO) in patients with locally advanced/metastatic cholangiocarcinoma and gallbladder cancer |
| Meeting Title: | ESMO Asia Congress 2018 |
| Journal Title: | Annals of Oncology |
| Volume: | 29 |
| Issue: | Suppl. 9 |
| Meeting Dates: | 2018 Nov 23-25 |
| Meeting Location: | Singapore |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2018-11-01 |
| Start Page: | ix66 |
| Language: | English |
| ACCESSION: | WOS:000458082200255 |
| PROVIDER: | wos |
| DOI: | 10.1093/annonc/mdy432.061 |
| Notes: | Meeting Abstract: 211TiP -- Source: Wos |
